Michael Brennan, Ph.D.

Michael Brennan serves as a member of ILiAD’s Scientific Advisory Board. Dr. Brennan spent more than 20 years at the US Food & Drug Administration, where he was an Associate Director at the Office of Vaccines Research and Review, and was also head of the Tuberculosis vaccine program. He is currently Senior Advisor for Scientific Affairs at Aeras where he develops strategies for the timely introduction of new Tuberculosis vaccines into low income countries, and works closely with National Regulatory Authorities responsible for clinical trial approval and new product licensure. In 2001, he worked in Geneva assisting the WHO in its development of a new Tuberculosis Vaccine Initiative. Dr. Brennan has published more than 100 scientific articles on vaccines and infectious diseases, and his early research paved the way for widespread Bordetella Pertussis immunizations. An authority on vaccine development and regulatory review, he sits on several international advisory committees, including the WHO and the US National Institutes of Health. He received a Ph.D. from Albany Medical College.

Copyright 2013-2017 ILiAD Biotechnologies